Reports And Data

The global extremity tissue expanders market size was USD 705.08 Million in 2022 and is expected to register a rapid revenue CAGR of 5%

NEW YORK, NY, UNITED STATES, May 3, 2023 /einpresswire.com / -- The extremity tissue expanders market is projected to experience a rapid revenue CAGR of 5% during the forecast period, with a global market size of USD 705.08 million in 2022. The market is being driven by several factors, including the growing demand for cosmetic procedures, rising cases of cancer and traumatic injuries, and increased public awareness about reconstructive procedures. Extremity tissue expanders are utilized in reconstructive surgery to encourage the growth of new skin, bone, or other tissues, and are effective in treating various congenital defects or secondary reconstruction of extensive burn scars. The market growth is also driven by technological advances in tissue expansion techniques and materials used in expanders.

However, there are certain factors that could potentially limit the growth of the market, such as high surgery costs, a shortage of qualified specialists, and government regulations. Moreover, the absence of insurance coverage for cosmetic procedures in certain regions and a lack of trained specialists for tissue growth procedures may also hinder market growth. Despite these challenges, the growing demand for extremities tissue expanders, particularly for aesthetic procedures such as breast augmentation, coupled with improvements in expanders' components and materials, is expected to drive market growth. The World Health Organization (WHO) predicts a 70% increase in new cancer cases over the next 20 years, which will likely increase the need for tissue expanders.

Get Free Sample PDF (To Understand the Complete Structure of this Report [Summary + TOC]) @

Segments Covered in the Report

The global extremity tissue expanders market is expected to experience rapid revenue growth with a CAGR of 5% during the forecast period from 2022 to 2032. The market size was estimated to be USD 705.08 million in 2022 and is projected to reach USD 1093.81 million in 2032. The report offers a detailed analysis of market trends in each segment and sub-segment from 2019 to 2032, with historical data from 2020 to 2021.

The market is segmented on the basis of type, application, and region. Based on type, the market is divided into upper extremity and lower extremity. Applications of the extremity tissue expanders include breast reconstruction, skin and soft tissue reconstruction, and others. The market is also segmented into regions such as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

The rising demand for cosmetic procedures, increasing number of cancer cases and traumatic injuries, and public awareness about reconstructive procedures are the major factors driving market revenue growth. Tissue expansion is a process used by reconstructive surgeons to help the body grow new skin, bone, or other tissues. Extremity tissue expanders are used for various reconstructive problems, ranging from the treatment of congenital defects to the secondary reconstruction of extensive burn scars. Technological developments in tissue expansion techniques and materials used in expanders are also driving the revenue growth of the market.

However, some factors could restrain market revenue growth, such as high surgery costs, shortage of qualified specialists, and onerous government regulations. Additionally, the high cost of procedures, the absence of insurance coverage for cosmetic procedures in some areas, and a lack of trained specialists for tissue growth procedures are other factors that could limit the market's revenue growth.

Overall, the report offers valuable insights into the global extremity tissue expanders market, with detailed analysis of market trends and segmentation by type, application, and region. It also provides revenue forecasts, company rankings, competitive landscape, growth factors, and trends, making it an essential tool for industry players and stakeholders.

Access Full Report Description with Research Methodology and Table of Contents @

Strategic development:

The extremity tissue expanders market is witnessing several strategic developments by key players to strengthen their market position. Some recent strategic developments in the market include:

Zimmer Biomet launched its Tissue Expander and Implant (TEI) System on 30 August 2021, designed to provide greater flexibility and control to surgeons during breast reconstruction procedures.

Stryker announced a strategic partnership with Conformis, a company specializing in patient-specific joint replacement implants, on 22 April 2021. The partnership aims to improve Stryker's product offerings in the orthopedic surgery market.

Boston Scientific Corporation announced the acquisition of the global surgical business of Lumenis Ltd. on 4 March 2021. Lumenis specializes in energy-based surgical solutions, and this acquisition aims to enhance Boston Scientific's product offerings in the surgical market.

Competitive Landscape:

The global extremity tissue expanders market is highly competitive with several major players vying for market share. To maintain their position in the market, these companies are adopting various strategies such as product innovation, strategic partnerships, and collaborations.

One such example is Zimmer Biomet, which recently launched its new Tissue Expander and Implant (TEI) System designed for use in breast reconstruction procedures. This new system is expected to provide surgeons with greater flexibility and control during the tissue expansion process. Similarly, Stryker announced a strategic partnership with Conformis, a medical technology company that specializes in patient-specific joint replacement implants. This partnership aims to enhance Stryker's product offerings in the orthopedic surgery market.

Boston Scientific Corporation has also been active in the market, announcing the acquisition of the global surgical business of Lumenis Ltd. This acquisition is aimed at enhancing Boston Scientific's product offerings in the surgical market.

Other key players in the market include Allergan, GC Aesthetics, Mentor Worldwide, Acelity L.P. Inc., and Dermatix. These companies are also investing in product development, strategic partnerships, and collaborations to maintain their market position and capitalize on the growing demand for extremity tissue expanders.

Request a customization of the report @

Browse More Reports:

Nikhil Morankar
Reports and Data
+ + 12127101370
email us here
Visit us on social media:
facebook
twitter
linkedin

MENAFN03052023003118003196ID1106159788